Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

L. Thompson · SciRah

Researcher profile · Semantic Scholar

L. Thompson

Share profile

L. Thompson — researcher profile on SciRah

h-index: 8
Works: 52
Citations: 243

Most-cited papers

Patterns of Cutaneous and Noncutaneous Immune-Related Adverse Events Among Patients With Advanced Cancer.
L. Thompson, N. Krasnow, Michael S Chang, Jaewon Yoon +9 more
2021JAMA dermatology50 citations Open access
Semantic Scholar
Effect of dermatological consultation on survival in patients with checkpoint inhibitor‐associated cutaneous toxicity
L. Thompson, Edward B. Li, N. Krasnow, M. S. Chang +11 more
2021British Journal of Dermatology24 citations
Semantic Scholar
Perceptions of medical status and treatment goal among older adults with advanced cancer.
L. Thompson, Brandon Temel, Charn-Xin Fuh, Christine Server +10 more
2019Journal of Geriatric Oncology19 citations
Semantic Scholar
Screening Tool Identifies Older Adults With Cancer at Risk for Poor Outcomes.
R. Nipp, L. Thompson, Brandon Temel, Charn-Xin Fuh +11 more
2020The Journal of the National Comprehensive Cancer Network17 citations
Semantic Scholar
Dermatology evaluation for cutaneous immune related adverse events is associated with improved survival in cancer patients treated with checkpoint inhibition
T. Jacoby, Nishi Shah, M. Asdourian, L. Thompson +6 more
2022Journal of American Academy of Dermatology14 citations Open access
Semantic Scholar
Impact of a case-based collaborative learning curriculum on knowledge and learning preferences of dermatology residents
J. Said, L. Thompson, Lynn Foord, S.-T. Chen
2020International Journal of Women's Dermatology12 citations Open access
Semantic Scholar
Palliative Care in Dermatology: A Clinical Primer, Review of the Literature, and Needs Assessment.
L. Thompson, S.-T. Chen, Andrew J. Lawton, A. Charrow
2020Journal of American Academy of Dermatology11 citations
Semantic Scholar
Impact of race on diagnosis and management of cutaneous toxicities from immune checkpoint inhibitors.
L. Thompson, Catherina X. Pan, Michael S Chang, N. Krasnow +2 more
2020Journal of American Academy of Dermatology8 citations Open access
Semantic Scholar
Prognostic significance of cutaneous immune-related adverse events in patients with melanoma and other cancers on immune checkpoint inhibitors.
L. Thompson, Michael S Chang, N. Polyakov, A. E. Blum +10 more
2021Journal of American Academy of Dermatology7 citations Open access
Semantic Scholar
Medical student perceptions of assessment systems, subjectivity, and variability on introductory dermatology clerkships
Jaewon Yoon, J. Said, L. Thompson, G. Molina +2 more
2021International Journal of Women's Dermatology7 citations Open access
Semantic Scholar
Patterns and prognostic significance of cutaneous immune-related adverse events in non-small cell lung cancer.
L. Thompson, E. Nadelmann, A. E. Blum, Jaewon Yoon +5 more
2021European Journal of Cancer7 citations
Semantic Scholar
Tumor-infiltrating lymphocytes as a predictive biomarker of cutaneous immune-related adverse events after immune checkpoint blockade in patients with advanced melanoma
Michael R. Stephens, M. Asdourian, T. Jacoby, Nishi Shah +7 more
2023Journal of American Academy of Dermatology6 citations Open access
Semantic Scholar
Association between serum lactate dehydrogenase and cutaneous immune-related adverse events among patients on immune checkpoint inhibitors for advanced melanoma
M. Asdourian, T. Otto, T. Jacoby, Nishi Shah +9 more
2022Journal of American Academy of Dermatology6 citations
Semantic Scholar
Methotrexate in the treatment of immune checkpoint blocker-induced bullous pemphigoid.
C. Shi, T. Otto, L. Thompson, Michael S Chang +2 more
2021European Journal of Cancer6 citations
Semantic Scholar
Association Between Systemic Corticosteroid Treatment for Cutaneous Immune-Related Adverse Events and Survival Outcomes in Patients With Advanced Cancer.
L. Thompson, Jaewon Yoon, N. Krasnow, Michael S Chang +3 more
2021JAMA dermatology6 citations Open access
Semantic Scholar
Impact of systemic corticosteroids on survival outcomes in immune checkpoint inhibitoreinduced gastroenterocolitis
L. Thompson, Ethan Katznelson, Donna E. Leet, S. Durbin +4 more
2020European Journal of Cancer6 citations Open access
Semantic Scholar
Development of multiple cutaneous immune-related adverse events among cancer patients after immune checkpoint blockade
M. Asdourian, Nishi Shah, T. Jacoby, Y. Semenov +5 more
2022Journal of American Academy of Dermatology5 citations Open access
Semantic Scholar
Diagnostic accuracy of general dermatologists and supportive oncodermatologists for biopsied cutaneous immune-related adverse events
L. Thompson, Jordan T. Said, Edward B. Li, Jaewon Yoon +6 more
2022Supportive Care in Cancer4 citations Open access
Semantic Scholar
Cutaneous Adverse Events to Immune Checkpoint Inhibitors in Pediatric Populations: A Retrospective Cohort Study.
L. McCormack, L. Thompson, Michael S Chang, N. Polyakov +3 more
2020Journal of American Academy of Dermatology4 citations Open access
Semantic Scholar
Association of pre‐existing drug allergies with cutaneous immune‐related adverse events among patients on immune checkpoint inhibitor therapy
T. Jacoby, T. Otto, M. Asdourian, Nishi Shah +5 more
2022British Journal of Dermatology3 citations Open access
Semantic Scholar
Histopathologically‐confirmed lichenoid eruptions from immune checkpoint inhibitor therapy: a retrospective cohort analysis
T. Jacoby, M. S. Chang, L. Thompson, R. Foreman +2 more
2021British Journal of Dermatology3 citations
Semantic Scholar
Non-cutaneous immune-related adverse events predict overall and progression-free survival in patients with cutaneous toxicities after immune checkpoint inhibitor therapy
M. Asdourian, T. Jacoby, Nishi Shah, T. Otto +5 more
2023Journal of American Academy of Dermatology2 citations Open access
Semantic Scholar
Low grade cutaneous immune related adverse events leading to immunotherapy discontinuation.
T. Jacoby, M. Asdourian, N. Shah, T. Otto +3 more
2023Clincal and Experimental Dermatology2 citations
Semantic Scholar
Evaluating patterns of co-occurrence between cutaneous and noncutaneous immune-related adverse events after immune checkpoint inhibitor therapy
M. Asdourian, Nishi Shah, T. Jacoby, L. Thompson +4 more
2022Journal of American Academy of Dermatology2 citations Open access
Semantic Scholar
Morphologic characteristics of cutaneous immune-related adverse events in patients receiving immune checkpoint inhibitors combined with other anticancer therapies: A multicenter retrospective study
M. Asdourian, T. Jacoby, Nishi Shah, L. Thompson +6 more
2022Journal of American Academy of Dermatology2 citations
Semantic Scholar
Cutaneous Toxicities of Immune Checkpoint Inhibitors in Patients with Altered Immunity.
L. Thompson, A. E. Blum, R. Reardon, N. Polyakov +4 more
2021Journal of American Academy of Dermatology2 citations Open access
Semantic Scholar
Patterns of cutaneous immune‐related adverse events in adults and children with advanced sarcoma: a retrospective cohort study
L. Thompson, M. S. Chang, L. McCormack, N. Polyakov +4 more
2020British Journal of Dermatology2 citations
Semantic Scholar
Associations between dermatologic immune-related adverse event morphologies and systemic immunomodulatory/immunosuppressive treatment: A large retrospective cohort study
R. Reardon, K. Perlman, M. Asdourian, Nishi Shah +5 more
2024Journal of American Academy of Dermatology1 citations
Semantic Scholar
Association between common medication triggers and severity of cutaneous immune-related adverse events.
Michael S Chang, L. Thompson, R. Reardon, Edward B. Li +6 more
2021Journal of American Academy of Dermatology1 citations
Semantic Scholar
Limitations of morphology-based management for immune checkpoint inhibitor-related cutaneous adverse events.
T. Otto, Michael S Chang, L. Thompson, S.-T. Chen
2021Journal of American Academy of Dermatology1 citations
Semantic Scholar
Alemtuzumab, total skin electron beam, and non‐myeloablative allogeneic haematopoietic stem‐cell transplantation in advanced sezary syndrome: a retrospective cohort study
L. Thompson, Catherina X. Pan, M. S. Chang, G. Molina +3 more
2021Journal of the European Academy of Dermatology and Venereology1 citations
Semantic Scholar
Impact of systemic corticosteroids on survival outcomes in patients with immune-checkpoint inhibitor enterocolitis.
L. Thompson, Ethan Katznelson, Donna E. Leet, S. Durbin +4 more
2020Journal of Clinical Oncology1 citations
Semantic Scholar
Tocilizumab and other targeted therapies for severe cutaneous immune‐related adverse events
L. Thompson, S.-T. Chen
2020British Journal of Dermatology1 citations
Semantic Scholar
506 Response to treatment of cutaneous immune-related adverse events following immune checkpoint inhibitor therapy
R. Reardon, K. Perlman, M. Asdourian, N. Shah +4 more
2023Journal of Investigative Dermatology0 citations
Semantic Scholar
Evaluating the treatment of cutaneous adverse events and adherence to National Comprehensive Cancer Network guidelines in patients receiving immune checkpoint inhibitors.
Michael S Chang, T. Jacoby, T. Otto, Nishi Shah +4 more
2022European Journal of Cancer0 citations
Semantic Scholar
LB927 Evaluating patterns of co-occurrence between cutaneous and non-cutaneous immune-related adverse events among cancer patients after immune checkpoint blockade
M. Asdourian, N. Shah, T. Jacoby, Y. Semenov +3 more
2022Journal of Investigative Dermatology0 citations Open access
Semantic Scholar
LB874 History of autoimmune disease associated with an increased risk of cutaneous immune related adverse events among patients with advanced cancer
T. Jacoby, N. Shah, M. Asdourian, N. Leboeuf +4 more
2022Journal of Investigative Dermatology0 citations Open access
Semantic Scholar
LB913 Low grade cutaneous immune related adverse events leading to immune checkpoint inhibitor discontinuation
T. Jacoby, M. Asdourian, N. Shah, L. Thompson +2 more
2022Journal of Investigative Dermatology0 citations Open access
Semantic Scholar
LB914 Dermatology evaluation of cutaneous immune related adverse event associated with higher checkpoint inhibitor retrial rates and improved survival
T. Jacoby, N. Shah, M. Asdourian, L. Thompson +5 more
2022Journal of Investigative Dermatology0 citations Open access
Semantic Scholar
Impact of systemic corticosteroids for cutaneous immune-related adverse events on survival outcomes in patients with advanced cancer: A retrospective cohort study.
Jaewon Yoon, L. Thompson, N. Krasnow, Michael S Chang +10 more
20210 citations
Semantic Scholar
LB743 Cutaneous immune-related adverse events are undertreated in advanced cancer patients
Michael S Chang, T. Otto, T. Jacoby, L. Thompson +2 more
20210 citations Open access
Semantic Scholar
Supplement to Cutaneous Toxicities of Immune Checkpoint Inhibitors in Patients with Altered Immunity
A. E. Blum, L. Thompson, R. Reardon, N. Polyakov +4 more
20210 citations
Semantic Scholar
28248 Medical student perceptions of assessment systems on introductory dermatology clerkships
J. Said, Jaewon Yoon, L. Thompson, G. Molina +1 more
20210 citations
Semantic Scholar
Relationship between insurance status and diagnosis of cutaneous immune-related adverse events.
Michael S Chang, N. Krasnow, A. E. Blum, V. Pahalyants +5 more
2021Journal of Clinical Oncology0 citations
Semantic Scholar
26711 Impact of biopsy and provider training on diagnostic accuracy of cutaneous immune-related adverse events
J. Said, L. Thompson, Edward B. Li, Jaewon Yoon +6 more
20210 citations
Semantic Scholar
Advanced care planning, code status and end‐of‐life care in patients with bullous pemphigoid
L. Thompson, J. Yoon, M. S. Chang, N. Polyakov +4 more
2021British Journal of Dermatology0 citations
Semantic Scholar
Mo1786 ELEVATED BREATH METHANE ON LACTULOSE BREATH TEST FOR SIBO INDEPENDENTLY PREDICTS IMPROVED OUTCOME AT 1-YEAR FOLLOWUP: A LONGITUDINAL STUDY USING PATIENT REPORTED OUTCOMES MEASURES
J. Hanifi, L. Thompson, A. Sanayei, R. Fox +1 more
20200 citations
Semantic Scholar
Discordance between recommended and delivered therapies for immunotherapy‐associated cutaneous toxicities in pediatric populations
L. Thompson, Michael S Chang, L. McCormack, N. Polyakov +3 more
2020Pediatric Blood & Cancer0 citations
Semantic Scholar
Cutaneous Adverse Events in Pediatric Populations: Supplemental Table 1
L. McCormack, L. Thompson, Michael S Chang, N. Polyakov +3 more
20200 citations
Semantic Scholar
Mo1527 ASSESSMENT OF REPONSE TO THERAPY IN SMALL INTESTINAL BACTERIAL OVERGROWTH (SIBO): AN ANALYSIS OF MULTIPLE VALIDATED PATIENT REPORTED OUTCOMES MEASURE INSTRUMENTS
Jasmine M. Hamfi, L. Thompson, A. Sanayei, R. Fox +1 more
20200 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

S.-T. Chen×40
Invite
S.-T. Chen — researcher profile on SciRah
K. Reynolds×23
Invite
K. Reynolds — researcher profile on SciRah
T. Jacoby×18
Invite
T. Jacoby — researcher profile on SciRah
Michael S Chang×17
Invite
Michael S Chang — researcher profile on SciRah

×16

Invite

M. Asdourian — researcher profile on SciRah

Jaewon Yoon×15

Invite

Jaewon Yoon — researcher profile on SciRah

N. Polyakov×15

Invite

N. Polyakov — researcher profile on SciRah

Invite

T. Otto — researcher profile on SciRah

Invite

N. Krasnow — researcher profile on SciRah

Invite

Y. Semenov — researcher profile on SciRah

Invite

G. Molina — researcher profile on SciRah

Invite

Nishi Shah — researcher profile on SciRah